Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Zeller, Scott L.
and
Wilson, Michael P.
2011.
Acute treatment of agitation in schizophrenia.
Drug Discovery Today: Therapeutic Strategies,
Vol. 8,
Issue. 1-2,
p.
25.
Shepherd, Andy R.
2011.
The benefits of an active control arm.
British Journal of Psychiatry,
Vol. 198,
Issue. 4,
p.
327.
Citrome, Leslie
and
Volavka, Jan
2011.
Pharmacological Management of Acute and Persistent Aggression in Forensic Psychiatry Settings.
CNS Drugs,
Vol. 25,
Issue. 12,
p.
1009.
Myers, D J
Spyker, D A
Dinh, K
Quintana, R J
Biondi, S A
and
Cassella, J V
2011.
Consistency of Dosing with a Thermal Aerosol Generation System:
In Vitro
and
In Vivo
Correlation
.
Future Medicinal Chemistry,
Vol. 3,
Issue. 13,
p.
1719.
Noymer, Peter
Biondi, Sherri
Myers, Dan
and
Cassella, James
2011.
Pulmonary Delivery of Therapeutic Compounds for Treating CNS Disorders.
Therapeutic Delivery,
Vol. 2,
Issue. 9,
p.
1125.
Buckley, Peter
2011.
Clinical News.
Clinical Schizophrenia & Related Psychoses,
Vol. 5,
Issue. 1,
p.
12.
Cipolla, David C.
and
Gonda, Igor
2011.
Formulation technology to repurpose drugs for inhalation delivery.
Drug Discovery Today: Therapeutic Strategies,
Vol. 8,
Issue. 3-4,
p.
123.
Gould, Cathleen M.
2012.
Psychopharmacologic Treatment of Acute Agitation.
Psychopharm Review,
Vol. 47,
Issue. 9,
p.
65.
Citrome, L.
2012.
Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.
International Journal of Clinical Practice,
Vol. 66,
Issue. 3,
p.
318.
Castle, David J.
Tran, Nga
Bosanac, Peter
and
Alderton, Deirdre
2012.
Pharmacological and Psychosocial Treatments in Schizophrenia.
p.
119.
Tran, Nga
Bosanac, Peter
and
Alderton, Deirdre
2012.
Pharmacological and Psychosocial Treatments in Schizophrenia, Third Edition.
p.
119.
Howland, Robert H.
2012.
Now Take a Deep Breath: Inhaled Loxapine for the Treatment of Acute Agitation.
Journal of Psychosocial Nursing and Mental Health Services,
Vol. 50,
Issue. 1,
p.
16.
Nordstrom, Kimberly
2012.
Inhaled loxapine for rapid treatment of agitation in schizophrenia and bipolar disorder: an update.
Neuropsychiatry,
Vol. 2,
Issue. 3,
p.
253.
Vangala, Rohini
Ahmed, Uzair
and
Ahmed, Rais
2012.
Loxapine inhaler for psychosis-induced aggression or agitation.
Cochrane Database of Systematic Reviews,
Kwentus, Joseph
Riesenberg, Robert A
Marandi, Morteza
Manning, Raymond A
Allen, Michael H
Fishman, Robert S
Spyker, Daniel A
Kehne, John H
and
Cassella, James V
2012.
Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo‐controlled clinical trial with inhaled loxapine.
Bipolar Disorders,
Vol. 14,
Issue. 1,
p.
31.
Wolf, Alexander
Müller, Matthias J.
and
Pajonk, Frank-Gerald B.
2013.
Impfungen im Alter.
CME,
Vol. 10,
Issue. 12,
p.
63.
Juckel, G.
2013.
Inhalatives Loxapin.
Der Nervenarzt,
Vol. 84,
Issue. 9,
p.
1113.
Nordstrom, Kimberly
and
Allen, Michael H.
2013.
Alternative Delivery Systems for Agents to Treat Acute Agitation: Progress to Date.
Drugs,
Vol. 73,
Issue. 16,
p.
1783.
Martel, Marc L.
Horn, Amanda E.
and
Dubin, William R.
2013.
Behavioral Emergencies for the Emergency Physician.
p.
164.
Keating, Gillian M.
2013.
Loxapine Inhalation Powder: A Review of its Use in the Acute Treatment of Agitation in Patients with Bipolar Disorder or Schizophrenia.
CNS Drugs,
Vol. 27,
Issue. 6,
p.
479.